In vitro, combined BRAF and MEK inhibition can induce rapid, non-mutational drug resistance, with a subpopulation of BRAF V600 mutant melanoma cells undergoing a reversible remodelling of mRNA translation [22]. The gene discussed is MAP2K7; the disease is melanoma.